GlassScriptPhysician profile
Jacqueline E Cohn
NPI 1851378863
$11,876.75
in general payments reported to CMS, 2019-2025
54 companies · $1,531 in 2025
The $1,531 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $1,673 · 2021: $2,259 · 2022: $1,644 · 2023: $1,909 · 2024: $1,507 · 2025: $1,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,847 · Gift: $59.40 · Education: $39.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,847.38 |
| Gift | $59.40 |
| Education | $39.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,058.84 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,130.64 | 2019-2025 | Jardiance, Mounjaro, Baqsimi |
| Abbvie INC. | $1,098.23 | 2019-2025 | Synthroid, Creon, Ubrelvy |
| Sanofi-Aventis U.S. LLC | $776.70 | 2019-2024 | |
| Medtronic, INC. | $720.44 | 2021-2024 | Minimed 780g |
| Mannkind Corporation | $642.77 | 2023-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.54 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Dexcom, INC. | $506.01 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $439.01 | 2020-2025 | Freestyle Libre |
| Insulet Corporation | $423.70 | 2019-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $374.76 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.00 | 2021-2025 | |
| Corcept Therapeutics | $296.25 | 2021-2025 | Korlym |
| Amarin Pharma, INC. | $233.50 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $225.04 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $224.47 | 2022-2025 | |
| Amgen INC. | $205.46 | 2019-2025 | Repatha, Tepezza, Repatha |
| Ascendis Pharma Endocrinology INC | $198.90 | 2025 | Yorvipath |
| Janssen Pharmaceuticals, INC | $122.31 | 2019-2021 | |
| Ibsa Pharma INC. | $111.37 | 2019-2025 | Tirosint, Licart, Flector |
| Merck Sharp & Dohme LLC | $110.96 | 2019 | |
| Esperion Therapeutics, INC. | $102.92 | 2020-2021 | |
| Chiesi USA, INC. | $64.88 | 2024 | Mycapssa |
| Xeris Pharmaceuticals, INC. | $63.08 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Lifescan, INC. | $62.24 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.01 | 2021 | |
| Roche Diabetes Care, INC. | $55.99 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $55.18 | 2025 | Imcivree |
| Medtronic Minimed, INC. | $53.17 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $52.90 | 2021-2024 | Isturisa, Signifor Lar |
| Cequr Corporation | $43.03 | 2022-2023 | Cequr Simplicity |
| Neurocrine Biosciences, INC. | $42.15 | 2025 | |
| Ascensia Diabetes Care US INC. | $39.84 | 2023 | |
| Amryt Pharma Holdings LTD | $34.98 | 2022-2023 | Mycapssa |
| Nevro Corp. | $34.00 | 2022 | |
| Horizon Therapeutics Plc | $33.93 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $29.79 | 2021 | |
| Radius Health, INC. | $28.33 | 2019-2023 | Tymlos |
| Ferring Pharmaceuticals INC. | $22.90 | 2024 | Menopur |
| Antares Pharma, INC. | $20.69 | 2024 | Xyosted |
| Madrigal Pharmaceuticals | $19.80 | 2025 | Rezdiffra |
| Regeneron Healthcare Solutions, INC. | $19.79 | 2019 | |
| Kyowa Kirin, INC. | $19.74 | 2025 | |
| Eusa Pharma (US) LLC | $18.74 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $18.68 | 2022 | |
| Sequel Med Tech, LLC | $18.13 | 2025 | Twiist |
| Bigfoot Biomedical INC | $17.90 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.52 | 2025 | Unithroid |
| Aytu Biopharma, INC. | $17.31 | 2019 | |
| Currax Pharmaceuticals LLC | $16.64 | 2022 | |
| Pfizer INC. | $14.81 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.02 | 2022 | |
| Beta Bionics, INC. | $12.56 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Vistapharm, INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.